Cabaletta Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CABA research report →
About the company
Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat autoimmune diseases where B cells are implicated in producing harmful autoantibodies.
- CEO
- Steven A. Nichtberger
- IPO
- 2019
- Employees
- 161
- HQ
- Philadelphia, PA, US
Price Chart
- Market Cap
- $520.14M
- P/E
- -1.62
- P/S
- 0.00
- P/B
- 3.46
- EV/EBITDA
- -2.51
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -131.58%
- ROIC
- -138.26%
- Revenue
- $0 · 0.00%
- Net Income
- $-167,856,000 · -44.87%
- EPS
- $-1.64 · 29.91%
- Op Income
- $-172,241,000
- FCF YoY
- -46.31%
- 52W High
- $4.23
- 52W Low
- $1.26
- 50D MA
- $3.31
- 200D MA
- $2.81
- Beta
- 3.26
- Avg Volume
- 4.46M
Get TickerSpark's AI analysis on CABA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | Tomasello Shawn | other | 22,000 |
| Jun 9, 26 | Simon Mark | other | 22,000 |
| Jun 9, 26 | HENRIQUES RICHARD C JR | other | 22,000 |
| Jun 9, 26 | Bollard Catherine | other | 22,000 |
| Jun 9, 26 | Brun Scott C. | other | 22,000 |
| Mar 2, 26 | Das Arun | other | 175,000 |
| Mar 2, 26 | Gerard Michael | other | 175,000 |
| Mar 2, 26 | Binder Gwendolyn | other | 225,000 |
| Mar 2, 26 | Chang David J. | other | 225,000 |
| Mar 2, 26 | Nichtberger Steven | other | 674,000 |
Our CABA coverage
Recent articles, reports, and earnings notes.
No research on CABA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CABA report →Similar companies
Peers in the same neighborhood.